• Healthcare Policy Pop Podcast
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • State Actions & Resources
    • Legislative Positions
    • Positions
    • Policy Supported
  • Take Action
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • State Actions & Resources
    • Legislative Positions
    • Positions
    • Policy Supported
  • Take Action
  • Donate

FDA

Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Sends Comments to FDA on OTC Naloxone

Feb 14, 2023 | FDA, Featured

Patients Rising Now submitted comments to the Food and Drug Administration (FDA) on making naloxone available as an over-the-counter treatment. Naloxone is a treatment which prevents death in the event of an opioid overdose and is currently only available through...
Read more
Patients Rising Now’s Comments on Oregon’s 1115 Waiver and Impact on Access

Patients Rising Now’s Comments on Oregon’s 1115 Waiver and Impact on Access

Jan 7, 2022 | FDA, Letters Submitted

The FDA’s Accelerated Approval Program provides a path for earlier approval of drugs being developed to treat serious diseases and address unmet medical need. The process allows the use of a surrogate endpoint—an indirect marker of clinical benefit that allows the...
Read more
Letter in support of the nomination of Dr. Robert Califf to serve as Commissioner of the Food and Drug  Administration

Letter in support of the nomination of Dr. Robert Califf to serve as Commissioner of the Food and Drug Administration

Jan 7, 2022 | FDA, Letters Submitted

On behalf of Patients Rising, the organization representing millions of Americans living with chronic disease, I write to support the nomination of Dr. Robert Califf to serve as Commissioner of the Food and Drug Administration. The U.S. Food and Drug Administration...
Read more
Letter in support of the nomination of Dr. Robert Califf to serve as Commissioner of the Food and Drug  Administration

S2 | E30: Pink Socks + Accelerated Approval for Drugs

Aug 9, 2021 | FDA, Featured, ICER, Podcast

On this episode of the podcast, Bob and Kate, filling in for Terry, discuss the attack on Food and Drug Administration accelerated approvals. They point to the recent criticism of the breakthrough Alzheimer’s drug Aduhelm as Exhibit A.  Bob explains how...
Read more

Categories

  • Access
  • Advocacy
  • California
  • Coalitions
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Update on Texas House Bill 999
  • PFPA Member Update – May 22, 2023
  • New Court Ruling May Restore Cost-sharing Barriers to Disease Prevention
  • Patients Rising Now Sends Letter of Support on PBM Bill
  • Patients Rising Now Signs onto Medigap Access Legislation

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now